Canada Blood Collection Devices Market (2025-2030)
The Canada Blood Collection Devices Market was valued at $323.3 Million in 2025 and projected to reach to $395 Million by 2030, representing a compound annual growth rate of 4.1%. Canada's blood collection devices market is experiencing steady growth driven by demographic and healthcare infrastructure factors.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada Blood Collection Devices Market Trends and Insights
- This steady expansion in Canada reflects increasing demand for advanced phlebotomy solutions driven by rising diagnostic testing volumes and an aging population requiring frequent blood work.
- Canada's healthcare infrastructure continues to modernize blood collection practices, with hospitals and diagnostic centers investing in safer, more efficient collection technologies. The Canadian market benefits from strong regulatory oversight and high healthcare spending, which support adoption of innovative blood collection devices.
- Canada's emphasis on patient safety and infection control standards accelerates the transition from conventional to advanced collection systems.
- Between 2025 and 2030, Canada is expected to see sustained growth as healthcare providers prioritize needle-stick injury prevention and improved specimen quality, positioning the country as a stable market within North America's broader blood collection device sector..
Key Market Statistics
- CAGR (2025-2030) 4.1% CAGR
- Market Size, 2025 ~USD 323.3 Million
- Forecast, 2030 ~USD 395 Million
- Country Canada
Canada Blood Collection Devices Market Overview
Market Size & Growth :
Canada's blood collection devices market is valued at $323.3 million in 2025, with a projected CAGR of 4.1% through 2030, reaching $395.0 million by forecast end.
Aging Population Driver :
Canada's demographic shift toward an older population is significantly increasing demand for frequent diagnostic blood work and phlebotomy services across healthcare facilities.
Healthcare Infrastructure Expansion :
Modernization of Canadian healthcare facilities and increased investment in diagnostic capabilities are driving adoption of advanced blood collection technologies and safety-engineered devices.
Diagnostic Testing Volume Growth :
Rising diagnostic testing volumes across Canadian hospitals, clinics, and laboratories are creating sustained demand for innovative and efficient blood collection solutions.
Canada Blood Collection Devices Market Dynamics
- The aging Canadian population requires increasingly frequent diagnostic testing, creating consistent demand for phlebotomy solutions.
- Healthcare providers are investing in advanced collection technologies to improve patient safety and operational efficiency.
- The 4.1% CAGR reflects a mature but expanding market with strong fundamentals.
- Looking ahead, continued healthcare modernization, regulatory emphasis on safety-engineered devices, and rising chronic disease prevalence will support market expansion through 2030..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Canada's blood collection devices market is valued at $323.3 million in 2025 and will reach $395.0 million by 2030 at a 4.1% CAGR.
- Canada's aging population and increased diagnostic testing demand are primary growth drivers for blood collection device adoption.
- Canada's stringent safety regulations and infection control standards favor adoption of advanced, safer collection technologies.
- Canada's stable healthcare spending and modernization initiatives support consistent market expansion through 2030.
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
Canada Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BLOOD BANKS | 50.7 | 52 | 52.7 | 53.6 | 54.8 | 56.2 | 57.9 | 59.7 | 2.5 |
| DIAGNOSTIC & PATHOLOGY LABS | 68.6 | 71.2 | 73.3 | 75.6 | 78.4 | 81.6 | 85.1 | 89.1 | 4 |
| HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES | 164 | 171.8 | 178.1 | 185.3 | 193.7 | 203 | 213.5 | 225.1 | 4.8 |
| OTHER END USERS | 18.7 | 19 | 19.2 | 19.4 | 19.8 | 20.2 | 20.6 | 21.2 | 2 |
| TOTAL | 302 | 313.9 | 323.3 | 333.9 | 346.7 | 361 | 377.1 | 395 | 4.1 |
Target Audience
- Medical Device Manufacturers : Manufacturers need Canada-specific market data to develop localized product strategies, understand regulatory requirements, and identify distribution partnerships in this $323M+ market.
- Healthcare Facility Administrators : Hospital and clinic leaders require market insights to benchmark procurement decisions, evaluate supplier options, and plan capital investments in blood collection infrastructure.
- Diagnostic Laboratory Operators : Lab managers need detailed market analysis to optimize equipment selection, forecast operational costs, and stay competitive in Canada's growing diagnostic testing sector.
- Healthcare Investors & Consultants : Investment firms and management consultants require Canada market data for due diligence, portfolio analysis, and strategic recommendations in the medical devices sector.
- Regulatory & Compliance Officers : Compliance professionals need market context and infrastructure data to navigate Canadian healthcare regulations, safety standards, and procurement requirements for blood collection devices.
Key Companies in the Canada Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Reasons to Buy this Report
- Market Size & Valuation Data : Access precise market sizing for Canada at $323.3M (2025) with detailed forecasts to 2030, enabling accurate budget allocation and revenue projections for Canadian operations.
- Growth Trajectory Analysis : Understand Canada's 4.1% CAGR in context of global 7.4% growth, identifying market maturity levels and competitive positioning opportunities specific to the Canadian healthcare landscape.
- Demographic & Healthcare Insights : Leverage Canada-specific data on aging population trends and diagnostic testing volume increases to identify high-potential customer segments and market expansion opportunities.
- Regulatory & Infrastructure Context : Gain insights into Canadian healthcare infrastructure modernization, safety device regulations, and facility investment patterns critical for product development and market entry strategies.
- Competitive Benchmarking : Compare Canadian market performance against global benchmarks to identify competitive gaps, pricing strategies, and differentiation opportunities in this specific geography.
Frequently asked questions
What is the current size of Canada's blood collection devices market?
Canada's blood collection devices market is valued at $323.3 million in 2025.
What is the projected market size for Canada by 2030?
Canada's blood collection devices market is projected to reach $395.0 million by 2030.
What is the growth rate for Canada's blood collection devices market?
Canada's blood collection devices market is expected to grow at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2030.
What factors are driving growth in Canada's blood collection devices market?
Growth in Canada is driven by an aging population, increased diagnostic testing volumes, emphasis on patient safety, infection control standards, and healthcare infrastructure modernization.
How does Canada's market compare to global trends?
Canada's 4.1% CAGR is more conservative than the global 7.4% CAGR, reflecting Canada's mature healthcare system and stable, regulated market environment.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- US Blood Collection Devices Market
- Germany Blood Collection Devices Market
- France Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Spain Blood Collection Devices Market
- Japan Blood Collection Devices Market
- China Blood Collection Devices Market
- India Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Europe Blood Collection Devices Market
- Rest Of Asia Pacific Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
